4/A: Fennec Pharmaceuticals Director Rosty Raykov Amends Filing to Correct Share Donation Error
SEC Filing
Director Rosty Raykov amends a previous Form 4 filing to accurately reflect a donation of 26,001 common shares to charity.
Summary
- Rosty Raykov, a director of Fennec Pharmaceuticals, filed an amended Form 4 with the SEC.
- The amendment corrects an error in the original filing related to a donation of common shares to a charity.
- The corrected filing includes the donation of 26,001 shares that were previously omitted.
- The transactions occurred on August 23, 2024.
- Raykov directly owns 66,432 common shares following the reported transactions.
Sentiment
Score: 7
Explanation: The document is a routine regulatory filing correcting a minor error, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, ensuring transparency in the market.
Key Dates
| Date | Description |
|---|---|
| 08/23/2024 | Date of the share donation transaction. |
| 08/26/2024 | Date of original Form 4 filing. |
| 08/27/2024 | Date of amended Form 4/A filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.